Functionally, CLCN3 is considered to be instrumental and indispensable in the control of inflammation of adipose tissue and obesity in mammals, and therefore, it has been useful in the therapeutic treatment of type 2 diabetic patients and obesity [15]. This evidence concerns the gene CLCN3 and obesity disorder.